000 01451 a2200433 4500
005 20250516020005.0
264 0 _c20110523
008 201105s 0 0 eng d
022 _a1432-0843
024 7 _a10.1007/s00280-010-1546-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYan, Zhao
245 0 0 _aA phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_cApr 2011
300 _a955-61 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aTime Factors
700 1 _aZhu, Zhongling
700 1 _aLi, Kai
700 1 _aChen, Peng
700 1 _aWang, Liuchun
700 1 _aHuang, Chun
700 1 _aXue, Jinhuai
700 1 _aLiu, Meijun
773 0 _tCancer chemotherapy and pharmacology
_gvol. 67
_gno. 4
_gp. 955-61
856 4 0 _uhttps://doi.org/10.1007/s00280-010-1546-z
_zAvailable from publisher's website
999 _c20478334
_d20478334